Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Hinge Health, Inc. (HNGE) Financial Statements

Hinge Health, Inc. (HNGE) reported trailing twelve-month revenue of $720.1M (up 49.8% year on year) and net income of $109.1M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $283.9M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HNGEHinge Health, Inc.Follow HNGE — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
9.0B
P/E TTM
86.4
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue292.7390.4587.9720.1
Gross profit194.2299.9468.2608.4
Research & development110.1100.8368.1129.1
Operating income-130.5-31.9-546.493.7
Pre-tax income-108.5-11.3-527.3111.0
Income tax-0.40.71.01.9
Net income-108.1-11.9-528.3109.1
Diluted EPS ($)-8.31-0.88-7.771.29
Diluted shares (mn)13.013.654.6—

USD millions · SEC XBRL

Hinge Health, Inc. — questions

What is Hinge Health, Inc.'s revenue?
$720.1M over the twelve months to 2026-06-30, up 49.8% year on year, from its 10-Q and 10-K filings.
What is Hinge Health, Inc.'s net income?
$109.1M over the twelve months to 2026-06-30.
What is Hinge Health, Inc.'s free cash flow?
$283.9M over the twelve months to 2026-06-30.
What are Hinge Health, Inc.'s diluted earnings per share?
$1.29 over the twelve months to 2026-06-30.

Every figure on this page comes from Hinge Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.